ArticleNPJ breast cancer2021

Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy.

Saeed S Akhand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.